Authors report anatomical and pathophysiologic aspects concerning lymphedema following breast cancer treatment. They underline clinical and lymphoscintigraphic criteria to define lymphedema-risk patients, in whom preventive measures are indicated. They propose a surgical primary prevention, by performing direct lymphatic-venous anastomosis at the same time of axillary nodal dissection (LY.M.P.H.A. - Lymphatic Microsurgical Preventing Healing Approach).
How to limit lymphatic morbidity in breast cancer treatment
Boccardo, F;Friedman, D;De Cian, F;Murelli, F;Santi, P;Campisi, C.
2012-01-01
Abstract
Authors report anatomical and pathophysiologic aspects concerning lymphedema following breast cancer treatment. They underline clinical and lymphoscintigraphic criteria to define lymphedema-risk patients, in whom preventive measures are indicated. They propose a surgical primary prevention, by performing direct lymphatic-venous anastomosis at the same time of axillary nodal dissection (LY.M.P.H.A. - Lymphatic Microsurgical Preventing Healing Approach).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
